Opaleye Management Inc.

Holdings History for OCULAR THERAPEUTIX, INC - Common Stock, par value $0.0001 per share (OCUL)

Symbol: OCUL on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 4.34M shares
Security Ownership: 2.76%

Shares, Excluding Options vs Price

Value, Excluding Options

Opaleye Management Inc. ownership in OCULAR THERAPEUTIX, INC Common Stock, par value $0.0001 per share (OCUL)

2025-02-14 - Opaleye Management Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.34M shares of OCULAR THERAPEUTIX, INC Common Stock, par value $0.0001 per share (OCUL). This represents 2.76% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Opaleye Management Inc.	2.76%		$31.8M	4.34M			$7.33	13G/A	12/31/2024	14 Feb 2025 06:46:48

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	6.49%	-1.02%	$37.1M	4.34M	-682,500	-13.6%	$8.54	Q4 2024
9/30/2024	7.29%	-0.41%	$43.7M	5.03M	-282,500	-5.32%	$8.70	Q3 2024
6/30/2024	8.29%	-2.02%	$36.3M	5.31M	-1,345,638	-20.2%	$6.84	Q2 2024
3/31/2024	13.2%	+1.42%	$60.5M	6.65M	+583,138	+9.61%	$9.10	Q1 2024
12/31/2023	7.2%	-0.58%	$27.1M	6.07M	-398,000	-6.15%	$4.46	Q4 2023
9/30/2023	6.61%	+0.7%	$20.3M	6.47M	+688,000	+11.9%	$3.14	Q3 2023
6/30/2023	7.13%	-0.4%	$29.8M	5.78M	-325,900	-5.34%	$5.16	Q2 2023
3/31/2023	9.64%	+0.05%	$32.2M	6.11M	+30,900	+0.51%	$5.27	Q1 2023
12/31/2022	5.94%	-0.38%	$17.1M	6.08M	-390,000	-6.03%	$2.81	Q4 2022
9/30/2022	11.1%	+0.84%	$26.8M	6.47M	+490,200	+8.2%	$4.15	Q3 2022
6/30/2022	10.8%		$24M	5.97M			$4.02	Q2 2022
3/31/2022	9.18%		$29.6M	5.97M			$4.95	Q1 2022
12/31/2021	8.83%	-0.75%	$41.6M	5.97M	-505,200	-7.8%	$6.97	Q4 2021
9/30/2021	12.1%		$64.8M	6.48M			$10.00	Q3 2021
6/30/2021	15.3%		$91.9M	6.48M			$14.18	Q2 2021
3/31/2021	15.6%	-0.07%	$106M	6.48M	-30,000	-0.46%	$16.41	Q1 2021
12/31/2020	17.6%	+1.42%	$135M	6.51M	+525,800	+8.79%	$20.70	Q4 2020
9/30/2020	8.91%		$45.5M	5.98M			$7.61	Q3 2020
6/30/2020	10.1%	+1.45%	$49.8M	5.98M	+861,700	+16.8%	$8.33	Q2 2020
3/31/2020	6.72%	+0.02%	$25.4M	5.12M	+15,000	+0.29%	$4.95	Q1 2020
12/31/2019	3.96%	+1.81%	$20.2M	5.11M	+2,332,500	+84.1%	$3.95	Q4 2019
9/30/2019	3.13%	-0.2%	$8.44M	2.78M	-175,000	-5.93%	$3.04	Q3 2019
6/30/2019	4.08%	+1.45%	$13M	2.95M	+1,050,000	+55.3%	$4.40	Q2 2019
3/31/2019	2.13%	+2.13%	$7.54M	1.9M	+1,900,000	NEW	$3.97	Q1 2019
12/31/2018		-1.4%	$0	0	-800,000	-100%		Q4 2018
9/30/2018	1.4%	-0.54%	$5.5M	800K	-311,000	-28%	$6.88	Q3 2018
6/30/2018	1.94%	+1.94%	$7.5M	1.11M	+1,111,000	NEW	$6.75	Q2 2018
6/30/2017		-2.57%	$0	0	-550,000	-100%		Q2 2017
3/31/2017	2.54%	+2.11%	$5.1M	550K	+456,400	+488%	$9.28	Q1 2017
12/31/2016	0.46%	+0.46%	$783K	93.6K	+93,600	NEW	$8.37	Q4 2016
9/30/2016		-0.89%	$0	0	-260,000	-100%		Q3 2016
6/30/2016	0.89%	+0.89%	$1.29M	260K	+260,000	NEW	$4.95	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.